Bone Marrow TransplantationTissue DonorsHistocompatibility TestingTransplantation, HomologousGraft vs Host DiseaseBone MarrowHistocompatibilityBone Marrow CellsGraft SurvivalTransplantation ChimeraWhole-Body IrradiationAnemia, AplasticTransplantation ConditioningTransplantation, AutologousLeukemiaSurvival AnalysisHematopoietic Stem Cell TransplantationBone and BonesHematopoietic Stem CellsGraft RejectionHLA AntigensLeukocyte TransfusionRadiation ChimeraTransplantation, IsogeneicLiver TransplantationGraft Enhancement, ImmunologicTransplantation ToleranceImmunosuppressionBone Marrow PurgingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRecurrenceMice, Inbred C57BLKidney TransplantationBone Marrow DiseasesBusulfanImmunosuppressive AgentsTreatment OutcomeTime FactorsSkin TransplantationTransplantation ImmunologyLymphocyte DepletionGraft vs Host ReactionT-LymphocytesBone Marrow ExaminationChimerismAcute DiseaseCyclophosphamidePrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisActuarial AnalysisLiving DonorsHeart TransplantationHematologic NeoplasmsTissue and Organ ProcurementBone Marrow NeoplasmsBlood DonorsCombined Modality TherapyLeukemia, Myeloid, AcuteRemission InductionLymphocyte Culture Test, MixedChimeraDisease-Free SurvivalHepatic Veno-Occlusive DiseaseLeukemia, MyeloidMice, Inbred BALB CColony-Forming Units AssayRetrospective StudiesBone RemodelingStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte TransfusionMyelodysplastic SyndromesCord Blood Stem Cell TransplantationSevere Combined ImmunodeficiencySurvival RateCell DifferentiationHematologic DiseasesFlow CytometryLung TransplantationCyclosporineMice, Inbred C3HPancytopeniaSpleenBone DensityImmune ToleranceAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyLeukocyte CountCarmustineOrgan TransplantationGranulocyte Colony-Stimulating FactorCells, CulturedGraft vs Tumor EffectFollow-Up StudiesCytarabineCytomegalovirus InfectionsMultiple MyelomaGraft vs Leukemia EffectAntigens, CD34Bone Resorption